Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR gamma by Cdk5

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Choi, J. H.
  • Banks, A. S.
  • Estall, J. L.
  • Kajimura, S.
  • Bostrom, P.
  • Laznik, D.
  • Ruas, J. L.
  • Chalmers, Michael
  • Kamenecka, Theodore
  • Bluher, M.
  • Griffin, Patrick
  • Spiegelman, B. M.

publication date

  • July 2010

journal

  • Nature  Journal

abstract

  • Obesity induced in mice by high-fat feeding activates the protein kinase Cdk5 (cyclin-dependent kinase 5) in adipose tissues. This results in phosphorylation of the nuclear receptor PPARgamma (peroxisome proliferator-activated receptor gamma), a dominant regulator of adipogenesis and fat cell gene expression, at serine 273. This modification of PPARgamma does not alter its adipogenic capacity, but leads to dysregulation of a large number of genes whose expression is altered in obesity, including a reduction in the expression of the insulin-sensitizing adipokine, adiponectin. The phosphorylation of PPARgamma by Cdk5 is blocked by anti-diabetic PPARgamma ligands, such as rosiglitazone and MRL24. This inhibition works both in vivo and in vitro, and is completely independent of classical receptor transcriptional agonism. Similarly, inhibition of PPARgamma phosphorylation in obese patients by rosiglitazone is very tightly associated with the anti-diabetic effects of this drug. All these findings strongly suggest that Cdk5-mediated phosphorylation of PPARgamma may be involved in the pathogenesis of insulin-resistance, and present an opportunity for development of an improved generation of anti-diabetic drugs through PPARgamma.

subject areas

  • Adipose Tissue
  • Amino Acid Sequence
  • Animals
  • Cell Line
  • Cyclin-Dependent Kinase 5
  • Diabetes Mellitus, Experimental
  • Dietary Fats
  • Humans
  • Insulin
  • Ligands
  • Mice
  • Models, Molecular
  • Obesity
  • PPAR gamma
  • Phosphorylation
  • Phosphoserine
  • Protein Conformation
  • Thiazolidinediones
scroll to property group menus

Identity

PubMed Central ID

  • PMC2987584

International Standard Serial Number (ISSN)

  • 0028-0836

Digital Object Identifier (DOI)

  • 10.1038/nature09291

PubMed ID

  • 20651683
scroll to property group menus

Additional Document Info

start page

  • 451

end page

  • 456

volume

  • 466

issue

  • 7305

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support